Hyaluronic Acid-Conjugated Carbon Nanomaterials for Enhanced Tumour Targeting Ability

Hyaluronic acid (HA) has been implemented for chemo and photothermal therapy to target tumour cells overexpressing the CD44(+) receptor. HA-targeting hybrid systems allows carbon nanomaterial (CNM) carriers to efficiently deliver anticancer drugs, such as doxorubicin and gemcitabine, to the tumour s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearns, Oisin, Camisasca, Adalberto, Giordani, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746509/
https://www.ncbi.nlm.nih.gov/pubmed/35011272
http://dx.doi.org/10.3390/molecules27010048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746509/
https://www.ncbi.nlm.nih.gov/pubmed/35011272
http://dx.doi.org/10.3390/molecules27010048

Ejemplares similares